These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1441293)

  • 21. Vasopressin antidiuretic agonist and antagonist activity in dogs: structural and stereochemical relationship between bridge and carboxyl terminus.
    Albrightson-Winslow CR; Brickson B; Brooks DP; Bryan WM; Caldwell N; Kinter LB; Moore ML; Nambi P; Stassen FL; Huffman WF
    J Pharmacol Exp Ther; 1991 Jan; 256(1):335-40. PubMed ID: 1988664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D; Gaffori O; Burbach JP; Kovács GL; van Ree JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular diversity of anticoagulants from haematophagous animals.
    Koh CY; Kini RM
    Thromb Haemost; 2009 Sep; 102(3):437-53. PubMed ID: 19718463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic peptides derived from midkine enhance plasminogen activator activity in bovine aortic endothelial cells.
    Kojima S; Inui T; Kimura T; Sakakibara S; Muramatsu H; Amanuma H; Maruta H; Muramatsu T
    Biochem Biophys Res Commun; 1995 Jan; 206(2):468-73. PubMed ID: 7826363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.
    Beyermann M; Fechner K; Furkert J; Krause E; Bienert M
    J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of single chain pro-UK on the initiation and regulation of fibrinolysis].
    Arimura H; Kasai S; Nishida M; Suyama T
    Rinsho Byori; 1989 Apr; Spec No 81():107-17. PubMed ID: 2502639
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of modified electroconvulsive therapy on vasopressin release and haemostasis in man.
    Hampton KK; Grant PJ; Boothby M; Dean HG; Davies JA; Prentice CR
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):293-7. PubMed ID: 2129414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity investigation of novel vasopressin hypotensive peptide agonists.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 1999 Nov; 5(11):472-90. PubMed ID: 10587312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A capillary hemostasis mechanism regulated by sympathetic tone and activity via factor VIII or von Willebrand's factor may function as a "capillary gate" and may explain angiodysplasia, angioneurotic edema, and variations in systemic vascular resistance.
    Coleman LS
    Med Hypotheses; 2006; 66(4):773-5. PubMed ID: 16338094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship of HP (2-20) analog peptide: enhanced antimicrobial activity by N-terminal random coil region deletion.
    Park Y; Park SC; Park HK; Shin SY; Kim Y; Hahm KS
    Biopolymers; 2007; 88(2):199-207. PubMed ID: 17216635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pegylated peptides. IV. Enhanced biological activity of site-directed pegylated GRF analogs.
    Felix AM; Lu YA; Campbell RM
    Int J Pept Protein Res; 1995; 46(3-4):253-64. PubMed ID: 8537179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanism of fibrinolysis--a system involved with malignant cells.
    Cederholm-Williams SA
    Invasion Metastasis; 1981; 1(2):85-98. PubMed ID: 6234253
    [No Abstract]   [Full Text] [Related]  

  • 34. Functional analysis of the amino- and carboxyl-termini of streptokinase.
    Fay WP; Bokka LV
    Thromb Haemost; 1998 May; 79(5):985-91. PubMed ID: 9609234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive activity of analogs of tripeptide Lys-Arg-Pro with D-amino acid residues.
    Siemion IZ; Kluczyk A; Słoń JJ; Zimecki M; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):205-7. PubMed ID: 7487354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
    Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
    J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships of vasopressin analogues on release of factor VIII in dogs.
    Vilhardt H; Barth T
    J Recept Res; 1991; 11(1-4):233-7. PubMed ID: 1715919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal regulation of the acute haemostatic response to stress.
    Grant PJ
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):299-306. PubMed ID: 2103314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A guide to murine fibrinolytic factor structure, function, assays, and genetic alterations.
    Matsuo O; Lijnen HR; Ueshima S; Kojima S; Smyth SS
    J Thromb Haemost; 2007 Apr; 5(4):680-9. PubMed ID: 17403202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.